| Filed On | Filing |
|---|---|
| 02 Oct 2026 |
Form 4: McMinn Rachel, Director
Received 756 shares by exercise or conversion ($19.1K) |
| 07 Jul 2026 |
Form 4: Cvijic Christine Mikail, Director
Sold 600 shares ($21.6K) · Sold 4,200 shares ($152K) |
| 02 Jul 2026 |
Form 4: Cvijic Christine Mikail, Director
Sold 739 shares ($25.2K) · Sold 4,061 shares ($141K) |
| 08 May 2026 |
Form 4: Cvijic Christine Mikail, Director
Sold 9,600 shares ($300K) |
| 07 May 2026 |
Form 4: Shafer Christina, Chief Commercial Officer
Granted 120,000 Non-Qualified Stock Option (right to buy) |
| 30 Mar 2026 |
Form 4: Cvijic Christine Mikail, President and CFO
Sold 2,558 shares ($55.3K) |
| 30 Mar 2026 |
Form 4: McMinn Rachel, Director
Sold 3,352 shares ($74K) |
| 30 Mar 2026 |
Form 4: Jordan Julie, Chief Medical Officer
Sold 828 shares ($18.1K) |
| 17 Mar 2026 |
Form 4: Cobb Stuart, Chief Scientific Officer
Sold 6,797 shares ($141K) |
| 17 Mar 2026 |
Form 4: Cvijic Christine Mikail, President and CFO
Sold 4,045 shares ($84.2K) |
| 03 Mar 2026 |
Form 4: Cvijic Christine Mikail, President and CFO
Sold 4,800 shares ($121K) |
| 24 Feb 2026 |
Form 4: Cobb Stuart, Chief Scientific Officer
Received 16,500 shares as a grant or award |
| 24 Feb 2026 |
Form 4: Jordan Julie, Chief Medical Officer
Received 4,900 shares as a grant or award · Granted 29,600 Stock Option (Right to Buy) |
| 24 Feb 2026 |
Form 4: Cvijic Christine Mikail, President and CFO
Received 22,000 shares as a grant or award · Granted 131,900 Stock Option (Right to Buy) |
| 24 Feb 2026 |
Form 4: McMinn Rachel, Director
Received 25,900 shares as a grant or award · Granted 155,100 Stock Option (Right to Buy) |
| 24 Feb 2026 |
Form 4: Palekar Rohan, Director
Granted 12,050 Non-Qualified Stock Option (right to buy) |
| 24 Feb 2026 |
Form 4: Baffi Robert, Director
Granted 12,050 Non-Qualified Stock Option (right to buy) |
| 24 Feb 2026 |
Form 4: Noonberg Sarah B., Director
Granted 12,050 Non-Qualified Stock Option (right to buy) |
| 24 Feb 2026 |
Form 4: Freedland Cory S., Director
Granted 12,050 Non-Qualified Stock Option (right to buy) |
| 24 Feb 2026 |
Form 4: Woods Keith, Director
Granted 12,050 Non-Qualified Stock Option (right to buy) |
Loading...